Poon, Jiat-Ling http://orcid.org/0000-0001-7038-2102
Marshall, Chris http://orcid.org/0000-0003-1486-8997
Johnson, Chloe http://orcid.org/0000-0002-2278-2176
Pegram, Hannah C. http://orcid.org/0000-0002-4446-4531
Hunter, Maile
Kan, Hongjun http://orcid.org/0000-0002-4585-5016
Ahmad, Nadia N.
Article History
Accepted: 30 June 2022
First Online: 22 July 2022
Declarations
:
: Jiat Ling Poon, Hongjun Kan, and Nadia N. Ahmad are employees and shareholders of Eli Lilly and -Company. Chris Marshall and Chloe Johnson are employees and stockholders of Clarivate, a health economic and outcomes research consultancy that consults with various pharmaceutical companies. Maile Hunter and Hannah C. Pegram were employees of Clarivate at the time this work was conducted.
: Ethics approval for the study was obtained from New England Independent Review Board (IRB#: 120190277; September 2019).
: All named authors have provided their consent for publication.
: All patients completed an informed consent form prior to interview and gave additional verbal consent at the time of the interview.